66 related articles for article (PubMed ID: 7797918)
1. Transplantation of skin from human immunodeficiency virus type 1-transgenic mice to normal congenic mice results in graft rejection.
Dumois JA; VanderVegt FP; Kopp JB; Marinos NJ; Rooney JF; Notkins AL
J Infect Dis; 1995 Jul; 172(1):232-4. PubMed ID: 7797918
[TBL] [Abstract][Full Text] [Related]
2. Effect of CD200 and CD200R1 expression within tissue grafts on increased graft survival in allogeneic recipients.
Yu K; Chen Z; Gorczynski R
Immunol Lett; 2013 Jan; 149(1-2):1-8. PubMed ID: 23178470
[TBL] [Abstract][Full Text] [Related]
3. In vivo treatment of mice with heat shock protein, gp 96, improves survival of skin grafts with minor and major antigenic disparity.
Kovalchin JT; Mendonca C; Wagh MS; Wang R; Chandawarkar RY
Transpl Immunol; 2006 Jan; 15(3):179-85. PubMed ID: 16431284
[TBL] [Abstract][Full Text] [Related]
4. Specific tolerance induction of allo-K(b)-skin grafts by FK506 in the CD8-depleted H-2(k) recipients required low amounts of K(b)-antigen.
Chen BG; Liu Z; Wu Y
Transpl Immunol; 2005 Oct; 15(1):9-16. PubMed ID: 16223668
[TBL] [Abstract][Full Text] [Related]
5. Organ-specific differences in the function of MCP-1 and CXCR3 during cardiac and skin allograft rejection.
Haskova Z; Izawa A; Contreras AG; Flynn E; Boulday G; Briscoe DM
Transplantation; 2007 Jun; 83(12):1595-601. PubMed ID: 17589343
[TBL] [Abstract][Full Text] [Related]
6. The pathological differences of rejection in the heart allografts which are transplanted alone or with synchronous skin grafts in rats.
Kogure K; Lim SM
Jpn J Exp Med; 1990 Oct; 60(5):279-83. PubMed ID: 2079750
[TBL] [Abstract][Full Text] [Related]
7. Survival of skin allografts is prolonged in mice with a dominant-negative H-Ras.
Funeshima-Fuji N; Fujino M; Kimura H; Takahara S; Nakayama T; Ezaki T; Li XK
Transpl Immunol; 2008 Feb; 18(4):302-6. PubMed ID: 18158115
[TBL] [Abstract][Full Text] [Related]
8. Presentation of the HPV16E7 protein by skin grafts is insufficient to allow graft rejection in an E7-primed animal.
Dunn LA; Evander M; Tindle RW; Bulloch AL; de Kluyver RL; Fernando GJ; Lambert PF; Frazer IH
Virology; 1997 Aug; 235(1):94-103. PubMed ID: 9300040
[TBL] [Abstract][Full Text] [Related]
9. Effect of localized cytokine dysregulation: accelerated rejection of IL-2-expressing skin grafts.
Blackburn C; Grogan JL; Augustine CL; Miller JF; Varigos G; Morahan G
Immunol Cell Biol; 2001 Apr; 79(2):128-31. PubMed ID: 11264705
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of portal venous tolerant long-term MHC Class I L(d)-specific skin graft survival in transgenic 2CF1 mice.
Margenthaler JA; Landeros K; Kataoka M; Flye MW
Transpl Immunol; 2003; 11(1):23-9. PubMed ID: 12727472
[TBL] [Abstract][Full Text] [Related]
11. Human growth hormone presented by K14hGH-transgenic skin grafts induces a strong immune response but no graft rejection.
Zhong J; Matsumoto K; De Kluyver R; Fernando GJ; Leggatt GR; Frazer IH
Immunol Cell Biol; 2004 Dec; 82(6):577-86. PubMed ID: 15550115
[TBL] [Abstract][Full Text] [Related]
12. Human CD4+ T cells mediate rejection of porcine xenografts.
Friedman T; Shimizu A; Smith RN; Colvin RB; Seebach JD; Sachs DH; Iacomini J
J Immunol; 1999 May; 162(9):5256-62. PubMed ID: 10228000
[TBL] [Abstract][Full Text] [Related]
13. Targeting of the hNC16A collagen domain to dendritic cells induces tolerance to human type XVII collagen.
Ettinger M; Gratz IK; Gruber C; Hauser-Kronberger C; Johnson TS; Mahnke K; Thalhamer J; Hintner H; Peckl-Schmid D; Bauer JW
Exp Dermatol; 2012 May; 21(5):395-8. PubMed ID: 22509840
[TBL] [Abstract][Full Text] [Related]
14. Skin allografts--lymph veiled (dendritic) cells are responsible for initiation of rejection in canine skin/SCID mouse chimera model.
Galkowska H; Olszewski WL; Moscicka M; Cybulska E; Ziolkowska A; Wojewodzka U; Mijal J
Ann Transplant; 1999; 4(3-4):5-10. PubMed ID: 10853773
[TBL] [Abstract][Full Text] [Related]
15. Differential involvement of CD4+ cells in mediating skin graft rejection against different amounts of transgenic H-2K(b) antigen.
Kawai M; Obata Y; Hamasima N; Takahashi T; Uenaka A; Monden M; Mori T; Shiku H; Nakayama E
J Exp Med; 1991 Jan; 173(1):261-4. PubMed ID: 1670639
[TBL] [Abstract][Full Text] [Related]
16. Cutaneous CsA-resistant veiled (dendritic) cells are responsible for uncontrolled skin allograft rejection.
Galkowska H; Moscicka M; Cybulska E; Wojewodzka U; Mijal J; Olszewski WL
Transplant Proc; 2001; 33(1-2):445-7. PubMed ID: 11266902
[No Abstract] [Full Text] [Related]
17. T cells reactive to a single immunodominant self-restricted allopeptide induce skin graft rejection in mice.
Valujskikh A; Matesic D; Gilliam A; Anthony D; Haqqi TM; Heeger PS
J Clin Invest; 1998 Mar; 101(6):1398-407. PubMed ID: 9502782
[TBL] [Abstract][Full Text] [Related]
18. Graft-infiltrating cells expressing a CD200 transgene prolong allogeneic skin graft survival in association with local increases in Foxp3(+)Treg and mast cells.
Gorczynski RM; Chen Z; Khatri I; Yu K
Transpl Immunol; 2011 Dec; 25(4):187-93. PubMed ID: 21801836
[TBL] [Abstract][Full Text] [Related]
19. Presensitization by skin grafting from major histocompatibility complex class I or major histocompatibility complex class II deficient mice identifies class I antigens as inducers of allosensitization.
Qian S; Fu F; Li Y; Gao L; Lu L; Noyola H; Rao AS; Thomson AW; Fung JJ
Immunology; 1995 May; 85(1):82-7. PubMed ID: 7635525
[TBL] [Abstract][Full Text] [Related]
20. Stro-1-positive human mesenchymal stem cells prolong skin graft survival in mice.
Zhang Y; Zhao D; Tian C; Li F; Li X; Zhang L; Yang H
Transplant Proc; 2013 Mar; 45(2):726-9. PubMed ID: 23498813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
